http://clinicalimmunologyinfo.com/topic/bristol-myers-squibb-company2010-09-01T12:14:37Z2010-09-01T12:14:37ZAP Newstag:clinicalimmunologyinfo.com,2010-09-01:/clinical-immunology/bristolmyers-signs-development-deal-alder-736278a/

<div id="subtitle"><a title="Bristol-Myers Squibb Company" href="/topic/Bristol-Myers+Squibb+Company" >Bristol-Myers Squibb</a> signs development deal for rheumatoid arthritis drug with Alder Biopharma</div><div><p>Bristol-Myers Squibb Co. and <a title="Alder Biopharmaceuticals Inc." href="/topic/Alder+Biopharmaceuticals+Inc." >Alder Biopharmaceuticals Inc.</a> said Tuesday they signed a collaboration deal potentially worth $1 billion, with a key focus on a rheumatoid arthritis treatment.</p><p>...

2010-07-22T06:30:31ZAP Newstag:clinicalimmunologyinfo.com,2010-07-22:/photo/earns-bristol-myers-2320308p/

FILE - In this file photograph taken July 27, 2006, <a title="Excedrin" href="/topic/Excedrin" >Excedrin</a> pain medication from <a title="Bristol-Myers Squibb Company" href="/topic/Bristol-Myers+Squibb+Company" >Bristol-Myers Squibb</a> is shown <a title="New York" href="/topic/New+York" >New York</a>. Drugmaker Bristol-Myers Squibb Co. said Thursday, July 22, 2010, its second-quarter sales are up a bit but profit is down nearly 6 percent, due to the sale of its interest in a nutrition busine...

2010-03-27T02:57:24ZAP Newstag:clinicalimmunologyinfo.com,2010-03-27:/photo/bristol-myers-ceo-2166323p/

In this photo released by <a title="Bristol-Myers Squibb Company" href="/topic/Bristol-Myers+Squibb+Company" >Bristol-Myers Squibb Co.</a>, newly named <a title="Lamberto Andreotti" href="/topic/Lamberto+Andreotti" >CEO Lamberto Andreotti</a> is shown. The drugmaker on Tuesday, March 2, 2010 said Andreotti will serve as CEO effective May 4, when current chairman and <a title="James Cornelius" href="/topic/James+Cornelius" >CEO James M. Cornelius</a> will retire. (AP Photo/Bristol-Myers Squibb, <...